Skip to main content
    H

    HCW Biologics Inc (HCWB)

    Official site

    HEALTHCARE • BIOTECHNOLOGY • NASDAQ

    $0.79
    +0.01 (+1.54%)

    Market Cap: $1.73M

    Last updated: Nov 17, 2026 at 10:58 AM ET

    HCW Biologics Inc (HCWB) Earnings: Report Dates and Results

    Updated Aug 14, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    In the quarter ended Jun 30, 2026, HCW Biologics reported EPS of -$10.10, below the -$1.98 estimate. It beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate.

    Earnings

    Performance (10Y)

    Beat Rate
    33%(6/18)
    Avg Surprise
    -59.49%

    Upcoming Estimates

    Report date not yet scheduledPeriod ending Dec 31, 2026
    EPS Consensus-$1.42
    RangeN/A
    3 analysts
    Revenue Consensus
    N/A
    RangeN/A
    3 analysts

    Next Report

    HCWB's report for the quarter ending Dec 31, 2026 is not on the earnings calendar yet.

    Earnings History

    Of the 18 quarters below that had an estimate, HCWB beat 6, missed 11 and matched 1. Revenue for the quarter ended Jun 30, 2026 was $135568, up 1969.7% from $6550 a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Jun 30, 2026-$10.10-$1.98-$1.98 - -$1.98-410.10%MissN/A10 up, 1 downAug 14, 2026$135568
    Mar 31, 2026$2.22-$2.64-$2.64 - -$2.64+184.09%BeatN/A11 up, 0 downMay 14, 2026$6.54M
    Dec 31, 2025-$6.12-$5.04N/A-21.43%MissN/A11 up, 0 downMar 31, 2026$27011
    Sep 30, 2025-$12.12$9.48$9.48 - $9.48-227.85%MissN/A11 up, 0 downNov 14, 2025$15606
    Jun 30, 2025-$6.79$10.80N/A-162.87%MissN/AN/A0 up, 0 downAug 18, 2025$6550
    Mar 31, 2025-$0.05N/AN/AN/AN/AN/AN/A0 up, 0 downMay 15, 2025$5065
    Dec 31, 2024-$19.20$21.60N/A-188.89%MissN/AN/AN/AMar 28, 2025$394803
    Sep 30, 2024-$24.00-$31.20N/A+23.08%BeatN/AN/AN/ANov 14, 2024$426423
    Jun 30, 2024-$96.00-$43.20N/A-122.22%MissN/AN/A0 up, 0 downAug 14, 2024$618854
    Mar 31, 2024-$72.00-$36.00N/A-100.00%MissN/AN/A0 up, 0 downMay 15, 2024$1.13M
    Dec 31, 2023-$0.30-$0.15N/A-106.90%MissN/A10 up, 0 downMar 26, 2024$1.32M
    Sep 30, 2023-$33.60-$31.20N/A-7.69%MissN/A20 up, 0 downNov 14, 2023$853102
    Jun 30, 2023-$28.80-$37.20-$38.39 - -$33.59+22.58%BeatN/A30 up, 0 downAug 11, 2023$622807
    Mar 31, 2023-$0.14-$0.14-$0.16 - -$0.120.00%In lineN/A20 up, 0 downMay 9, 2023$41883
    Dec 31, 2022-$36.00-$34.80N/A-3.45%MissN/A20 up, 0 downMar 28, 2023$1.34M
    Sep 30, 2022-$26.40-$31.20N/A+15.38%BeatN/A10 up, 0 downNov 7, 2022$1.81M
    Jun 30, 2022-$24.00-$30.00-$33.59 - -$26.39+20.00%BeatN/A20 up, 0 downAug 12, 2022$454000
    Mar 31, 2022-$14.40-$33.60N/A+57.14%BeatN/A10 up, 0 downMay 13, 2022$3.12M
    Dec 31, 2021-$0.17-$0.12-$0.12 - -$0.12-41.67%MissN/A20 up, 0 downMar 29, 2022N/A
    Sep 30, 2021-$0.08N/AN/AN/AN/AN/AN/AN/ANov 12, 2021N/A
    Jun 30, 2021-$0.20N/AN/AN/AN/AN/AN/AN/AAug 13, 2021N/A
    Mar 31, 2021-$0.66N/AN/AN/AN/AN/AN/AN/AJun 30, 2021N/A
    Dec 31, 2020-$0.69N/AN/AN/AN/AN/AN/AN/AMar 31, 2021$4.10M
    Jun 30, 2020-$0.63N/AN/AN/AN/AN/AN/AN/ASep 30, 2020N/A
    Mar 31, 2020-$0.65N/AN/AN/AN/AN/AN/AN/AJun 30, 2020N/A
    Dec 31, 2019-$0.56N/AN/AN/AN/AN/AN/AN/AMar 31, 2020N/A
    Last 26 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was -$25.08, after -$211.20 the year before. It was -$0.56 for the year ended Dec 31, 2019, the oldest of the 7 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025-$25.08N/A
    Dec 31, 2024-$211.20N/A
    Dec 31, 2023-$62.84N/A
    Dec 31, 2022-$100.80N/A
    Dec 31, 2021-$1.11N/A
    Dec 31, 2020-$1.96N/A
    Dec 31, 2019-$0.56N/A

    Frequently Asked Questions About HCWB

    Did HCWB beat earnings estimates last quarter?

    No. HCW Biologics reported EPS of -$10.10 for the quarter ended Jun 30, 2026, below the -$1.98 estimate by 410.10%.

    What EPS do analysts expect from HCWB next quarter?

    The consensus EPS estimate for HCW Biologics for the quarter ending Dec 31, 2026 is -$1.42 from 3 analysts.

    How often does HCWB beat earnings estimates?

    HCW Biologics beat the EPS estimate in 2 of the 8 most recent quarters that had an estimate, with an average surprise of -115.77%.